Implantable brain-computer interface trials and the gap between device ambition and post-trial protections
NeuroData · 21.10.2026 · 3 · 182
DOI: 10.63688/neurodata2026182 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroData, online erschienen am 21.10.2026. Verfasst von Lucía Gerez und 1 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Implantable brain-computer interfaces are advancing quickly from first-in-human safety studies toward larger and longer registrations, yet the post-trial obligations owed to implanted participants remain contested.
Methods
Cross-sectional registry study of all interventional trials of implanted brain-computer interfaces, coded for design, endpoints, participant protections and post-trial provisions, with publication linkage to the biomedical literature.
Results
Of 116 included trials, 26.7% declared any post-trial provision (31 of 116; 95% CI 19.5-35.4), 16.4% declared a data-sharing plan, and none offered expanded access. A data monitoring committee was present in 38.8% and predicted a linked publication (OR 5.34; 95% CI 1.72-16.56; p = 0.004). Sponsor class did not predict post-trial provisions (industry OR 1.91; 95% CI 0.64-5.70).
Conclusions
Post-trial provisions remain the exception rather than the norm across a rapidly growing field, and the deficit is not explained by sponsor class or development stage; monitoring infrastructure, not commercial status, predicts transparency.
Zitieren
APA
Gerez, L., & Celis, A. P. (2026). Implantable brain-computer interface trials and the gap between device ambition and post-trial protections. NeuroData, 3, 182. https://doi.org/10.63688/neurodata2026182
Vancouver
Gerez L, Celis AP. Implantable brain-computer interface trials and the gap between device ambition and post-trial protections. NeuroData. 2026;3:182. doi:10.63688/neurodata2026182
BibTeX
@article{Gerez2026,
author = {Gerez, Lucía and Celis, Avryl Paredes},
title = {Implantable brain-computer interface trials and the gap between device ambition and post-trial protections},
journal = {NeuroData},
year = {2026},
volume = {3},
pages = {182},
doi = {10.63688/neurodata2026182}
}
EUVIMED